Zobrazeno 1 - 10
of 373
pro vyhledávání: '"Sarah E Hoffe"'
Autor:
JM Bryant, Russell F Palm, Roberto Herrera, Muni Rubens, Sarah E Hoffe, Dae Won Kim, Adeel Kaiser, Antonio Ucar, Jason Fleming, Fernando De Zarraga, Pamela Hodul, Santiago Aparo, Horacio Asbun, Mokenge Malafa, Ramon Jimenez, Jason Denbo, Jessica M Frakes, Michael D. Chuong
Publikováno v:
Cancer Control, Vol 30 (2023)
Purpose Treatment options for pancreatic ductal adenocarcinoma (PDAC) are commonly limited for patients with advanced age due to medical comorbidities and/or poor performance status. These patients may not be candidates for more aggressive chemothera
Externí odkaz:
https://doaj.org/article/98fa1c6c7c71415db1998dca42512612
Autor:
Elie Barakat, MD, Andras Bibok, MD, Anupam Rishi, MD, Altan Ahmed, MD, Jessica M. Frakes, MD, Sarah E. Hoffe, MD, Avan J. Armaghani, MD, Aixa E. Soyano, MD, Ricardo L.B. Costa, MD, Ghassan El-Haddad, MD, Junsung Choi, MD, Bela Kis, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 1, Pp 100838- (2022)
Purpose: Our purpose was to retrospectively evaluate the safety and efficacy of transarterial hepatic radioembolization (TARE) treatment with yttrium-90 labeled glass microspheres in patients with chemotherapy-refractory breast cancer with liver-domi
Externí odkaz:
https://doaj.org/article/2f74ad0e84814633ae43295babdba3e2
Autor:
Jordan McDonald, BA, Chine-Yu Chuang, BA, J. Kevin Hicks, PharmD, PhD, Darcy K. Berry, MS, CGC, Iman Imanirad, MD, Anupam Rishi, MD, Jessica M. Frakes, MD, Sarah E. Hoffe, MD, Seth Felder, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100717- (2021)
Externí odkaz:
https://doaj.org/article/02e07573424a4fd1b39038c97e028687
Autor:
Austin J. Sim MD, JD, Gage Redler PhD, Jeffrey Peacock MD, Cristina Naso MEd, Stuart Wasserman MS, Khadija B. McNitt BSN, OCN, Sarah E. Hoffe MD, Peter A. S. Johnstone MD, Louis B. Harrison MD, Stephen A. Rosenberg MD, MS
Publikováno v:
Cancer Control, Vol 27 (2020)
Emergence of the COVID-19 crisis has catalyzed rapid paradigm shifts throughout medicine. Even after the initial wave of the virus subsides, a wholesale return to the prior status quo is not prudent. As a specialty that values the proper application
Externí odkaz:
https://doaj.org/article/fb561d74c00949f3bbd4970cc94a0e16
Autor:
Russell F. Palm, Emanuel Boyer, Dae W. Kim, Jason Denbo, Pamela J. Hodul, Mokenge Malafa, Jason B. Fleming, Ravi Shridhar, Michael D. Chuong, Eric A. Mellon, Jessica M. Frakes, Sarah E. Hoffe
Publikováno v:
HPB.
Autor:
Bela Kis, Ravi Shridhar, Rahul Mhaskar, Marcell Gyano, Jessica M. Frakes, Ghassan El-Haddad, Junsung Choi, Richard D. Kim, Sarah E. Hoffe
Publikováno v:
Journal of Vascular and Interventional Radiology.
Autor:
Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Giuseppe Malleo, Ryan K. Schmocker, Raëf Abdallah, Changhoon Yoo, Walid L. Shaib, Marcel André Schneider, Elena Rangelova, Yoo Jin Choi, Hongbeom Kim, J. Bart Rose, Sameer Patel, Gregory C. Wilson, Sarah Maloney, Lea Timmermann, Klaus Sahora, Fabian Rössler, Víctor Lopez-Lopez, Emanuel Boyer, Laura Maggino, Thomas Malinka, Jeong Youp Park, Matthew H. G. Katz, Laura Prakash, Syed A. Ahmad, Scott Helton, Jin-Young Jang, Sarah E. Hoffe, Roberto Salvia, Julien Taieb, Jin He, Pierre-Alain Clavien, Ulrike Held, Kuno Lehmann
Publikováno v:
Annals of Surgical Oncology.
Autor:
Dilmurodjon Eshmuminov, Botirjon Aminjonov, Russell F. Palm, Giuseppe Malleo, Ryan K. Schmocker, Raëf Abdallah, Changhoon Yoo, Walid L. Shaib, Marcel André Schneider, Elena Rangelova, Yoo Jin Choi, Hongbeom Kim, J. Bart Rose, Sameer Patel, Gregory C. Wilson, Sarah Maloney, Lea Timmermann, Klaus Sahora, Fabian Rössler, Víctor Lopez-Lopez, Emanuel Boyer, Laura Maggino, Thomas Malinka, Jeong Youp Park, Matthew H. G. Katz, Laura Prakash, Syed A. Ahmad, Scott Helton, Jin-Young Jang, Sarah E. Hoffe, Roberto Salvia, Julien Taieb, Jin He, Pierre-Alain Clavien, Ulrike Held, Kuno Lehmann
Publikováno v:
Annals of Surgical Oncology.
Background Pancreatic cancer often presents as locally advanced (LAPC) or borderline resectable (BRPC). Neoadjuvant systemic therapy is recommended as initial treatment. It is currently unclear what chemotherapy should be preferred for patients with
Autor:
null JM Bryant, null Russell F Palm, null Roberto Herrera, null Muni Rubens, null Sarah E Hoffe, null Dae Won Kim, null Adeel Kaiser, null Antonio Ucar, null Jason Fleming, null Fernando De Zarraga, null Pamela Hodul, null Santiago Aparo, null Horacio Asbun, null Mokenge Malafa, null Ramon Jimenez, null Jason Denbo, null Jessica M Frakes, null Michael D. Chuong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d17d2f86a6d0035d3b17abb61ecc6448
https://doi.org/10.1177/10732748221150228/v3/response1
https://doi.org/10.1177/10732748221150228/v3/response1
Autor:
Sarah E. Hoffe, Mokenge P. Malafa, Jason B. Fleming, Samer A Naffouje, Jason W. Denbo, Pamela J. Hodul, Arvind Sabesan, Estrella Carballido, Dae-Won Kim, Jessica M. Frakes
Publikováno v:
Journal of Gastrointestinal Surgery. 26:376-386
The impact of adjuvant sequential chemoradiotherapy (CRT) on survival in resected pancreatic ductal adenocarcinoma (PDAC) remains unclear and warrants further investigation. NCDB patients with R0/R1 resected PDAC who received adjuvant chemotherapy wi